![WT Financial Group Limited](/common/images/company/ASX_WTL.png)
Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 PR Newswire SAN DIEGO, July 30, 2024 SAN DIEGO, July 30, 2024 /PRNewswire/ -- Heron Therapeutics...
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System PR Newswire SAN...
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire SAN DIEGO, July 2, 2024 -The U.S. Food and Drug...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.003 | -3.75 | 0.08 | 0.08 | 0.075 | 65056 | 0.07854383 | DE |
4 | -0.002 | -2.53164556962 | 0.079 | 0.083 | 0.075 | 70329 | 0.07989333 | DE |
12 | 0.01 | 14.9253731343 | 0.067 | 0.083 | 0.061 | 91688 | 0.07424242 | DE |
26 | 0.004 | 5.47945205479 | 0.073 | 0.083 | 0.06 | 216031 | 0.06594181 | DE |
52 | 0.001 | 1.31578947368 | 0.076 | 0.105 | 0.06 | 176469 | 0.07114093 | DE |
156 | -0.023 | -23 | 0.1 | 0.14 | 0.06 | 133005 | 0.08143891 | DE |
260 | 0.027 | 54 | 0.05 | 0.14 | 0.023 | 118979 | 0.07956055 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約